Prevent skin breakdown and scar formation
Clinicians play a key role in recognizing and preventing skin disorders that may adversely affect a patients quality of life. It is important to prevent skin breakdown and protect fragile or vulnerable skin against external influences. But prevention continous even after wound closure as avoiding the formation of excessive scar tissues may be essential for patient's wellbeing.
Prevent the skin of pressure ulcers
Both the Linovera® oil and emulsion of hyperoxynated fatty acids (HOFA) are indicated for the prevention and treatment of stage 1 pressure ulcers. Lower limb ulcers (vascular and diabetic foot) can be treated and prevented with Linovera® Emulsion.
For optimal protection of uninjured skin on the heel combine Linovera® with Askina® Heel to prevent pressure ulcers.
Protect the skin of excessive body fluid exposure
Askina® Barrier efficiently prevents skin breakdown associated with excessive body fluid exposure. It acts as a lasting protective barrier on patients' skin. When applied, it is quickly absorbed, leaving an invisible breathable water repellent layer, resistant to wash-off.
Askina® Scar Repair is a soft silicone self-adhesive dressing that is indicated to prevent the formation of excessive scar tissues and to manage scars in a non-invasive way.
Skin Care - Take the Lead Brochure
|pdf (2.2 MB)||open|
Did you know?
Overhydratation causes swelling & disruption of strateumcorneum (1)
After exposure to excessive moisture, the skin becomes damp, soggy and clammy, its permeability can be breached and it is susceptible to physical damage from friction and shearing forces.
pH of the skin increases due to urine and feces. (2)
The increase in the normal acidic pH of the skin (4–6.8) due to the alkalinity of urine and faeces encourages bacterial colonisation.
29% incontinence associated dermatitis (3/4)
Incontinence-associated dermatitis, a clinical manifestation of moisture-associated skin damage is a common consideration in patients with fecal and/or urinary incontinence.
100 million patients develop scars (5)
Incontinence-associated dermatitis, a clinical manifestation of moisture-associated skin damage common consideration in patients with fecal and/or urinary incontinence.
A total of 100 million patients develop scars in the developed world alone each year as a result of 55 million elective operations and 25 million operations after trauma.
Remove barriers to healing
1) D Beeckman et al. Proceedings of the Global IAD Expert Panel. Incontinence associated dermatitis: moving prevention forward. Wounds International 2015. Available to download from www.woundsinternational.com
2) K Ousey et al. The identification and management of moisture lesions. Wounds UK, 2012; Moisture Lesions Supplement. Wounds UK, London
3) Heywood, N. Holloway, S. Risk factors for incontinence- associated dermatitis: an evidence-based review. Wounds UK 2014, Vol 10, No 4. 22-33
4) Johansen, E., Bakken, L. N., Duvaland, E., Faulstich, J., Hoelstad, H. L., Moore, Z., … Beeckman, D. (2018). Incontinence-Associated Dermatitis (IAD). Journal of Wound, Ostomy and Continence Nursing, 45(6), 527–531.
5) G Gauglitz et al. Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Molecular Medicine, 2011; 17(1-2):113-125
6) Jiménez Torres, J. Ácidos Grasos Hiperoxigenados (AGHO) en el tratamiento y prevención de las úlceras por presión, úlceras vasculares y pie diabético. Panorama actual del medicamento 2010; 34 (336):695-701
7) Declair V. The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers. Ostomy Wound Manage. 1997;43(5):48-52, 54.
8) Colin D, Chomard D, Bois C, Saumet JL, Desvaux B, Marie M. An evaluation of hyper-oxygenated fatty acid esters in pressure sore management. J Wound Care. 1998;7(2):71-2.
9) Kiezel-Tsugunova M, Kendall AC, Nicolaou A. Fatty acids and related lipid mediators in the regulation of cutaneous inflammation. Biochem Soc Trans. 2018 Feb 19;46(1):119-129. doi: 10.1042/ BST20160469 Ajouter au projet Citavi par DOI. Epub 2018 Jan 12. PMID: 29330355 Ajouter au projet Citavi par Pubmed-ID.
10) Cravotto G. et all. An evaluation of the potential of 1000 plants. Journal of Clinical Pharmacy and Therapeutics, 2010 35:1:11-48